[go: up one dir, main page]

NO961221D0 - Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse - Google Patents

Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse

Info

Publication number
NO961221D0
NO961221D0 NO961221A NO961221A NO961221D0 NO 961221 D0 NO961221 D0 NO 961221D0 NO 961221 A NO961221 A NO 961221A NO 961221 A NO961221 A NO 961221A NO 961221 D0 NO961221 D0 NO 961221D0
Authority
NO
Norway
Prior art keywords
site
cancer metastasis
genes associated
identifying new
new genes
Prior art date
Application number
NO961221A
Other languages
English (en)
Inventor
Oeystein Fodstad
Original Assignee
Oeystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oeystein Fodstad filed Critical Oeystein Fodstad
Priority to NO961221A priority Critical patent/NO961221D0/no
Publication of NO961221D0 publication Critical patent/NO961221D0/no
Priority to IL12625797A priority patent/IL126257A/xx
Priority to JP9534283A priority patent/JP2000509250A/ja
Priority to CN97193361A priority patent/CN1214738A/zh
Priority to BR9708256A priority patent/BR9708256A/pt
Priority to TR1998/01916T priority patent/TR199801916T2/xx
Priority to CA002250202A priority patent/CA2250202A1/en
Priority to PL97329038A priority patent/PL185182B1/pl
Priority to KR1019980707486A priority patent/KR19990087833A/ko
Priority to RU98119525/14A priority patent/RU2180963C2/ru
Priority to PCT/NO1997/000083 priority patent/WO1997036004A1/en
Priority to DE69725297T priority patent/DE69725297T2/de
Priority to AT97915776T priority patent/ATE251223T1/de
Priority to EP97915776A priority patent/EP0894146B1/en
Priority to HU9901786A priority patent/HUP9901786A3/hu
Priority to CZ982865A priority patent/CZ286598A3/cs
Priority to AU23116/97A priority patent/AU703262B2/en
Priority to SK1416-98A priority patent/SK282091B6/sk
Priority to NZ331920A priority patent/NZ331920A/xx
Priority to NO984489A priority patent/NO984489L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
NO961221A 1996-03-26 1996-03-26 Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse NO961221D0 (no)

Priority Applications (20)

Application Number Priority Date Filing Date Title
NO961221A NO961221D0 (no) 1996-03-26 1996-03-26 Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse
NZ331920A NZ331920A (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
KR1019980707486A KR19990087833A (ko) 1996-03-26 1997-03-25 부위-우선 암 전이 형성과 관련된 유전자 확인에 사용된 면역자성 세포분리
PCT/NO1997/000083 WO1997036004A1 (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
CN97193361A CN1214738A (zh) 1996-03-26 1997-03-25 用于鉴定与部位偏爱性癌转移形成有关的基因的免疫-磁性细胞分离技术
BR9708256A BR9708256A (pt) 1996-03-26 1997-03-25 Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo
TR1998/01916T TR199801916T2 (xx) 1996-03-26 1997-03-25 Kanser olu�umuyla ilgili genlerin belirlenmesinde kullan�lan h�cre ayr��t�rmas�.
CA002250202A CA2250202A1 (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
PL97329038A PL185182B1 (pl) 1996-03-26 1997-03-25 Sposób identyfikacji genów o miejscowo-swoistej albo miejscowo-wybiórczej ekspresji w swoistych nowotworowych komórkach docelowych oraz zastosowanie sposobu identyfikacji genów
IL12625797A IL126257A (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation for use in identification of genes associated with site-preferenced cancer methastasis formation
RU98119525/14A RU2180963C2 (ru) 1996-03-26 1997-03-25 Иммуномагнитное разделение клеток, используемое для идентификации генов, ассоциированных с сайт-предпочтительным образованием метастазов рака
JP9534283A JP2000509250A (ja) 1996-03-26 1997-03-25 部位特定ガン転移巣発生に伴う遺伝子識別のための免疫性磁気細胞分離
DE69725297T DE69725297T2 (de) 1996-03-26 1997-03-25 Immuno-magnetische zelltrennung zur erkennung von krebsmetastasenbildung-assozierten genen
AT97915776T ATE251223T1 (de) 1996-03-26 1997-03-25 Immuno-magnetische zelltrennung zur erkennung von krebsmetastasenbildung-assozierten genen
EP97915776A EP0894146B1 (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer metastasis formation
HU9901786A HUP9901786A3 (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with sitepreferenced cancer methastasis formation
CZ982865A CZ286598A3 (cs) 1996-03-26 1997-03-25 Způsob imunomagnetického oddělování buněk
AU23116/97A AU703262B2 (en) 1996-03-26 1997-03-25 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
SK1416-98A SK282091B6 (sk) 1996-03-26 1997-03-25 Spôsob imunomagnetického oddeľovania buniek
NO984489A NO984489L (no) 1996-03-26 1998-09-25 Immunomagnetisk celleseparasjon anvendt til identifikasjon av gener assosiert med setepreferert cancermetastasedannelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO961221A NO961221D0 (no) 1996-03-26 1996-03-26 Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse

Publications (1)

Publication Number Publication Date
NO961221D0 true NO961221D0 (no) 1996-03-26

Family

ID=19899192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961221A NO961221D0 (no) 1996-03-26 1996-03-26 Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse

Country Status (19)

Country Link
EP (1) EP0894146B1 (no)
JP (1) JP2000509250A (no)
KR (1) KR19990087833A (no)
CN (1) CN1214738A (no)
AT (1) ATE251223T1 (no)
AU (1) AU703262B2 (no)
BR (1) BR9708256A (no)
CA (1) CA2250202A1 (no)
CZ (1) CZ286598A3 (no)
DE (1) DE69725297T2 (no)
HU (1) HUP9901786A3 (no)
IL (1) IL126257A (no)
NO (1) NO961221D0 (no)
NZ (1) NZ331920A (no)
PL (1) PL185182B1 (no)
RU (1) RU2180963C2 (no)
SK (1) SK282091B6 (no)
TR (1) TR199801916T2 (no)
WO (1) WO1997036004A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425138D0 (en) 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6828157B1 (en) 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
FR2804126B1 (fr) * 2000-01-21 2005-09-30 Patrick Rambaud Procede et systeme de gestion de lots de cellules immuno-competentes prelevees sur des sujets humains ou animaux en vue d'utilisations differees
FR2816322A1 (fr) * 2000-11-06 2002-05-10 Epigene Methode de separation d'acide nucleique differemment exprime entre une cellule cible et une cellule de reference
AU2002214689A1 (en) * 2000-11-06 2002-05-15 Bio-Tech Imaging, Inc. Method and kits for detecting hepatitis infected cells
CN115064209B (zh) * 2022-08-17 2022-11-01 普瑞基准科技（北京）有限公司 一种恶性细胞鉴定方法及系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
NO180658C (no) * 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner

Also Published As

Publication number Publication date
PL329038A1 (en) 1999-03-01
PL185182B1 (pl) 2003-03-31
DE69725297D1 (de) 2003-11-06
TR199801916T2 (xx) 1998-12-21
SK282091B6 (sk) 2001-10-08
SK141698A3 (en) 2000-01-18
CZ286598A3 (cs) 1999-02-17
HUP9901786A2 (hu) 1999-09-28
NZ331920A (en) 2000-01-28
EP0894146A1 (en) 1999-02-03
BR9708256A (pt) 1999-08-03
AU2311697A (en) 1997-10-17
WO1997036004A1 (en) 1997-10-02
RU2180963C2 (ru) 2002-03-27
JP2000509250A (ja) 2000-07-25
IL126257A (en) 2003-09-17
ATE251223T1 (de) 2003-10-15
DE69725297T2 (de) 2004-08-05
IL126257A0 (en) 1999-05-09
KR19990087833A (ko) 1999-12-27
EP0894146B1 (en) 2003-10-01
AU703262B2 (en) 1999-03-25
CN1214738A (zh) 1999-04-21
CA2250202A1 (en) 1997-10-02
HUP9901786A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
Facher et al. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin‐dependent kinase inhibitor gene
Cuatrecasas et al. K‐ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases
ATE91154T1 (de) Hybridisierungsverfahren zum nachweis genetischer stoffe.
AU2014899A (en) Metastatic breast and colon cancer regulated genes
ATE386804T1 (de) Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
ATE454463T1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
ATE445710T1 (de) Verfahren zur charakterisierung disseminierter und mikrometastasierter krebszellen
Festoff Serine proteases and their serpin inhibitors in the nervous system: regulation in development and in degenerative and malignant disease
NO961221D0 (no) Fremgangsmåte til å identifisere nye gener assosiert med setepreferert cancer mestastasedannelse
WO1997018454A3 (en) Method for identifying metastatic sequences
MXPA04003931A (es) Pronostico de cancer de mama.
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
EP0045573A3 (en) Eukaryotic autonomously replicating segment
PT1058739E (pt) Metodo para produzir perfis de expressao genica
Kostyuk et al. Increased Transfection of the Easily Oxidizable GC‐Rich DNA Fragments into the MCF7 Breast Cancer Cell
ATE60360T1 (de) Sonde und verfahren zum nachweis von bestimmten mikroorganismen, naemlich legionella, in diese enthaltenden medien.
Ariyanayagam-Baksh et al. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma
Keshava et al. Genomic instability in silica-and cadmium chloride-transformed BALB/c-3T3 and tumor cell lines by random amplified polymorphic DNA analysis
HK1118861A1 (en) Genes differentially expressed in breast cancer
Mahmood et al. Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9
ATE357535T1 (de) Genetische veränderungen im zusammenhang mit krebs
Schlechte et al. TP53 gene in blood plasma DNA of tumor patients
WO2001088546A3 (en) Treatments and markers for cancers of the central nervous system
Gress The „concerted action
Denis et al. 138 O-Detection of colorectal carcinoma metastases in blood